Pages

Tuesday, February 25, 2020

Pharma Reviews: Is specialty business 'a go or a no-go' segment for pharma companies?

Indian pharma companies have been toying with different strategies to build their US business as the traditional low-cost model of selling generic ...
Read more: Is specialty business 'a go or a no-go' segment for pharma companies?